In xenografted mice, CRISPR/Cas9 plasmid-loaded sEVs efficiently suppressed the expression of poly (ADP-ribose) polymerase-1 (PARP-1), inducing apoptosis in ovarian cancer and making the cells more sensitive to cisplatin (Figure 3B) [152]. Here, PARP1 is linked to ovarian cancer.